The historical rank and industry rank for Dominari Holdings's Net Margin % or its related term are showing as below:
FRA:BP2A'
s Net Margin % Range Over the Past 10 Years
Min: -305320 Med: -1122.22 Max: 6167.86
Current: -721.11
FRA:BP2A's Net Margin % is ranked worse than 69.72% of 1027
companies
in the Biotechnology industry
Industry Median: -151.78
vs FRA:BP2A: -721.11
Dominari Holdings Net Margin % Historical Data
The historical data trend for Dominari Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dominari Holdings's Net Margin %
For the Biotechnology subindustry, Dominari Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dominari Holdings's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dominari Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Dominari Holdings's Net Margin % falls into.
Dominari Holdings Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Dominari Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dominari Holdings (FRA:BP2A) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Dominari Holdings Net Margin % Related Terms
Thank you for viewing the detailed overview of Dominari Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:BP2A has been successfully added to your 